✦ LIBER ✦

Su2090 A Population Pharmacokinetic Model From a Phase 2 Study of Tofacitinib (CP-690,550), an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

✍ Scribed by Gao, Xiang; Krishnaswami, Sriram; Mukherjee, Arnab

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 Study of CP-690,550, an Oral Jan

✍ William J. Sandborn; Subrata Ghosh; Julian Panes; Ivana Vranic; Chinyu Su; J. Sp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Phase 2 Randomized Study of CP-690,550,

✍ William J. Sandborn; Subrata Ghosh; Julian Panes; Ivana Vranic; J. Spanton; Wojc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Tofacitinib (CP-690,550), an oral Janus

✍ Mamolo, C.; Harness, J.; Tan, H.; Menter, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Tu1109 Evaluation of the Relationship Be

✍ Sandborn, William; Panes, Julian; Zhang, Haiying; Yu, Dahong; Niezychowski, Wojc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 639 KB

P245 Evaluation of the relationship betw

✍ Panés, J.; Sandborn, W.J.; Zhang, H.; Yu, D.; Niezychowski, W.; Su, C. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 65 KB

The itch severity item: Mediation modeli

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB